Upstaging and Survival Outcomes for Non-Muscle Invasive Bladder Cancer After Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.

Journal: Journal of endourology
Published Date:

Abstract

We sought to describe the incidence, risk factors, and survival outcomes associated with pathologic upstaging from non-muscle invasive bladder cancer (NMIBC) to muscle invasive bladder cancer (MIBC) after robot-assisted radical cystectomy (RARC). We reviewed the International Robotic Cystectomy Consortium database between 2004 and 2020. Upstaging was defined as ≥pT or pathologic node positive (pN+) at final pathology analysis from clinical

Authors

  • Umar Iqbal
    Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Ahmed S Elsayed
    1 A.T.L.A.S (Applied Technology Laboratory for Advanced Surgery) Program, Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Zhe Jing
    1 A.T.L.A.S (Applied Technology Laboratory for Advanced Surgery) Program, Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Michael Stöckle
    University of the Saarland, Homburg Saar, Germany.
  • Carl Wijburg
    Department of Urology, Robotic Surgery, Rijnstate Hospital, Arnhem, The Netherlands.
  • Peter Wiklund
    Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
  • Abolfazl Hosseini
  • Prokar Dasgupta
  • Mohammad Shamim Khan
    Guy's Hospital, London, United Kingdom.
  • Ashok Hemal
    Department of Urology, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA.
  • Eric Kim
  • Andrew A Wagner
    Department of Urology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Franco Gaboardi
    Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Koon Ho Rha
    Department of Urology, Yonsei University College of Medicine, Seoul, Korea.
  • Thomas J Maatman
    Metro Health Hospital, Wyoming, Michigan, USA.
  • Derya Balbay
    Koç University Hospital, Istanbul, Turkey.
  • Qiang Li
    Department of Dermatology, Air Force Medical Center, PLA, Beijing, People's Republic of China.
  • Ahmed A Hussein
    Department of Urology, Applied Technology Laboratory for Advanced Surgery (ATLAS) Program at Roswell Park Cancer Institute, Buffalo, NY; Department of Urology, Cairo University, Cairo, Egypt.
  • Khurshid A Guru